Total Payments
$19,200
2024 Payments
$3,017
Companies
40
Transactions
1,320
Medicare Patients
1,381
Medicare Billing
$225,334
Payment Breakdown by Category
Food & Beverage$18,641 (97.1%)
Education$558.68 (2.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $18,641 | 1,307 | 97.1% |
| Education | $558.68 | 13 | 2.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $3,280 | 213 | $0 (2024) |
| ABBVIE INC. | $2,471 | 149 | $0 (2024) |
| PFIZER INC. | $1,935 | 257 | $0 (2024) |
| UCB, Inc. | $1,599 | 88 | $0 (2024) |
| Janssen Biotech, Inc. | $1,568 | 79 | $0 (2024) |
| Lilly USA, LLC | $1,308 | 90 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,227 | 63 | $0 (2024) |
| Genentech USA, Inc. | $864.39 | 49 | $0 (2024) |
| Horizon Therapeutics plc | $672.87 | 40 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $643.18 | 47 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,017 | 200 | Amgen Inc. ($617.25) |
| 2023 | $2,516 | 179 | Amgen Inc. ($364.53) |
| 2022 | $2,658 | 175 | Amgen Inc. ($464.84) |
| 2021 | $2,095 | 135 | Amgen Inc. ($489.29) |
| 2020 | $2,088 | 120 | Amgen Inc. ($602.17) |
| 2019 | $2,295 | 180 | Lilly USA, LLC ($326.29) |
| 2018 | $2,497 | 178 | PFIZER INC. ($332.65) |
| 2017 | $2,033 | 153 | AbbVie, Inc. ($314.75) |
All Payment Transactions
1,320 individual payment records from CMS Open Payments — Page 1 of 53
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 12/17/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: Dermatology | ||||||
| 12/12/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $33.17 | General |
| Category: Immunology | ||||||
| 12/10/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: Inflammation | ||||||
| 12/09/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $2.95 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/03/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $26.33 | General |
| Category: Immunology | ||||||
| 12/03/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $2.16 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/03/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $1.55 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/02/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $24.49 | General |
| Category: IMMUNOLOGY | ||||||
| 11/27/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $5.39 | General |
| Category: Inflammation | ||||||
| 11/26/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 11/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: Immunology | ||||||
| 11/19/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: Inflammation | ||||||
| 11/18/2024 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $9.40 | General |
| Category: Immunology | ||||||
| 11/18/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $8.08 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/18/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $1.71 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/14/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $16.51 | General |
| Category: Opioid Analgesic | ||||||
| 11/14/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $16.51 | General |
| Category: Opioid Analgesic | ||||||
| 11/12/2024 | Organon Llc | HADLIMA (Drug) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: ADALIMUMAB-BWWD | ||||||
| 11/12/2024 | Organon Llc | HADLIMA (Drug) | Food and Beverage | In-kind items and services | $0.97 | General |
| Category: ADALIMUMAB-BWWD | ||||||
| 11/11/2024 | Genentech USA, Inc. | Actemra (Biological) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: Immunology | ||||||
| 11/11/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $3.66 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/07/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $34.89 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 346 | 857 | $115,185 | $57,011 |
| 2022 | 7 | 354 | 895 | $120,893 | $55,362 |
| 2021 | 7 | 377 | 783 | $130,827 | $66,156 |
| 2020 | 5 | 304 | 624 | $108,445 | $46,806 |
Total Patients
1,381
Total Services
3,159
Medicare Billing
$225,334
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 226 | 528 | $89,760 | $46,356 | 51.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 63 | 63 | $19,215 | $9,456 | 49.2% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 20 | 20 | $3,000 | $726.80 | 24.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 13 | 33 | $2,145 | $316.10 | 14.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 24 | 213 | $1,065 | $156.01 | 14.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 221 | 502 | $85,340 | $41,404 | 48.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 53 | 53 | $16,165 | $7,823 | 48.4% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 11 | 54 | $6,220 | $2,791 | 44.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 20 | 24 | $3,048 | $1,339 | 43.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 19 | 110 | $7,150 | $1,179 | 16.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 11 | 17 | $2,295 | $716.76 | 31.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 19 | 135 | $675.00 | $108.74 | 16.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 228 | 562 | $95,540 | $49,408 | 51.7% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 78 | 78 | $23,790 | $12,825 | 53.9% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | Office | 2021 | 13 | 30 | $3,450 | $1,654 | 47.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 14 | 16 | $2,032 | $904.51 | 44.5% |
| 77080 | Bone density measurement of the core or central skeleton (e.g., hips, pelvis, spine) | Office | 2021 | 16 | 16 | $2,400 | $584.32 | 24.3% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 11 | 48 | $3,120 | $517.00 | 16.6% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2021 | 17 | 33 | $495.00 | $263.36 | 53.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 197 | 491 | $81,015 | $35,344 | 43.6% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 63 | 63 | $18,900 | $8,911 | 47.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 18 | 22 | $2,640 | $1,221 | 46.3% |
| 76881 | Complete ultrasound of joint of arm or leg | Office | 2020 | 11 | 22 | $5,500 | $1,128 | 20.5% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2020 | 15 | 26 | $390.00 | $202.41 | 51.9% |
About Dr. Matthew Call, D.O
Dr. Matthew Call, D.O is a Rheumatology healthcare provider based in Springville, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/16/2011. The National Provider Identifier (NPI) number assigned to this provider is 1083904619.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Matthew Call, D.O has received a total of $19,200 in payments from pharmaceutical and medical device companies, with $3,017 received in 2024. These payments were reported across 1,320 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($18,641).
As a Medicare-enrolled provider, Call has provided services to 1,381 Medicare beneficiaries, totaling 3,159 services with total Medicare billing of $225,334. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Location Springville, UT
- Active Since 04/16/2011
- Last Updated 12/04/2023
- Taxonomy Code 207RR0500X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1083904619
Products in Payments
- Enbrel (Biological) $2,586
- XELJANZ (Drug) $1,592
- Cimzia (Drug) $1,500
- RINVOQ (Biological) $1,071
- TALTZ (Drug) $1,044
- TREMFYA (Drug) $926.63
- Humira (Biological) $679.70
- KRYSTEXXA (Biological) $672.87
- ORENCIA (Biological) $643.18
- Rituxan (Biological) $574.48
- COSENTYX (Biological) $572.14
- COSENTYX (Drug) $474.11
- SAPHNELO (Biological) $436.21
- BENLYSTA (Biological) $393.50
- REMICADE (Biological) $320.82
- KRYSTEXXA (Drug) $307.35
- EVENITY (Biological) $301.44
- SIMPONI ARIA (Biological) $295.40
- Otezla (Drug) $284.87
- Rasuvo (Drug) $273.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.